Cancer Pain: all 343 studies
Page 4 of 4. Open to participants first (74), then studies with results posted, then the rest; newest registration first within each.
- Opioid Titration in the Hospice Setting: Barriers Assessment and Modification of the Model Order Sheet and ProtocolCompletedNCT01230515
- Instanyl® Non-Interventional StudyCompletedNCT01045603
- The Effect of Cancer Pain Management Protocol on Hospitalized Cancer Patients: A Pilot StudyCompletedNCT01043068Phase 4
- Cancer Pain Single Nucleotide Polymorphisms (SNPs)CompletedNCT00956878
- Methadone Hydrochloride as First-Line Therapy in Treating Patients With Chronic Neuropathic Cancer PainTerminatedNCT00930332Phase 1
- A Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Cancer-related PainCompletedNCT00929188Phase 2
- Safety of Fentanyl TAIFUN TreatmentStatus unknownNCT00822614Phase 3
- Gene Transfer for Cancer PainCompletedNCT00804076Phase 1
- An Efficacy and Safety Study of Low-dose Transdermal Therapeutic System (TTS)-Fentanyl D-Trans in Taiwan Participants With Cancer PainCompletedNCT00771199Phase 4
- Opioids With or Without Olanzapine in Treating Patients With Moderate to Severe Cancer PainWithdrawnNCT00737191Not applicable
- Safety & Efficacy Study of Subcutaneous Tetrodotoxin for Moderate to Severe Inadequately Controlled Cancer-related PainCompletedNCT00725114Phase 3
- A Phase III Clinical Study of KW-2246 for Breakthrough Pain in Cancer PatientsCompletedNCT00684632Phase 3
- A Phase III Clinical Study of KW-2246CompletedNCT00683995Phase 3
- Corticosteroids for Cancer PainCompletedNCT00676936Phase 3
- High Intensity Focused Ultrasound Tumor Treatment for Pancreatic Cancer PainSuspendedNCT00637364Phase 1/2
- A Study to Assess the Safety and Tolerability of Oxycodone Hydrochloride 50mg/mL Administered as an InfusionTerminatedNCT00626600Phase 3
- A Study to Evaluate the Safety and Effectiveness of Fentanyl-TTS Compared to Weak Opioids in Patients With Moderate to Severe Chronic Cancer Pain Previously Treated With NSAIDS (Non-steroidal Anti-inflammatory Drugs).CompletedNCT00576017Phase 4
- Prevalence of Secondary Hypogonadism in Male Patients on Chronic Opioid Therapy for Cancer-Related Pain SyndromesTerminatedNCT00529230
- Switching From Morphine to Oral Methadone Plus Acetaminophen in the Treatment of Cancer PainStatus unknownNCT00525967Phase 2/3
- A Study Comparing Oxycodone to Oxycodone/Naloxone in Moderate to Severe, Chronic Cancer PainCompletedNCT00513656Phase 2
- Ambulatory Cancer Pain Management: A Feasibility StudyCompletedNCT00507351
- Ketamine Associated With Opioids in Refractory Cancer Pain TreatmentCompletedNCT00484484Phase 3
- Efficacy & Safety Study of Nasalfent (Fentanyl Citrate Nasal Spray) for Treatment of Breakthrough Cancer Pain in Patients Taking Regular OpioidsCompletedNCT00459277Phase 3
- A Repeated-Dose Evaluation of Use of a Pain Relieving Drug and Safety of OROS Hydromorphone HCI in Patients With Chronic Cancer PainCompletedNCT00411034Phase 3
- Safety and Tolerability of Long-term Administration of OROS Hydromorphone HCI (Slow Release) in Cancer PainCompletedNCT00410787Phase 3
- A Study of OROS Hydromorphone HCL vs Morphine in Cancer Pain Patients.CompletedNCT00410540Phase 3
- Usefulness of Acupuncture in Cancer Pain and Quality of LifeCompletedNCT00401063Not applicable
- Oxycodone or Standard Pain Therapy in Treating Patients With Cancer PainCompletedNCT00378937Phase 4
- Clinical Study of KW-2246 in Patients With Cancer PainCompletedNCT00355628Phase 2
- Analgesia and Wound Healing Assessment Following Topical Morphine Applied to Patients With Cutaneous Cancer Related PainWithdrawnNCT00306020Not applicable
- Coaching to Improve Care of Cancer PainCompletedNCT00283166Not applicable
- Efficacy and Safety of FITpatch Compared to Standard Opioid Treatment in Cancer Pain (FT-015-IN)CompletedNCT00279344Phase 3
- Evaluation of the Efficacy and Safety of Fentanyl Delivered by Adhesive Skin Patch in Out-Patients With Chronic Cancer PainTerminatedNCT00236327Phase 4
- Phase II Clinical Trial of Fentanyl Transdermal Matrix Patch, in the Management of Cancer Pain- Assessment of Effectiveness, Safety and Pharmacokinetics -CompletedNCT00216658Phase 2
- Acetaminophen for Cancer PainCompletedNCT00152854Phase 3
- Acupuncture For Pancreatic Cancer PainCompletedNCT00136669Phase 3
- Study 767905/008 Extension Study: Alvimopan for Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain SubjectsCompletedNCT00135577Phase 2
- Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Moderate to Severe Cancer PainTerminatedNCT00126789Phase 3
- The Pain Pen for Breakthrough Cancer PainTerminatedNCT00125801Phase 3
- Pilot Study to Evaluate the Safety and Analgesic Activity of M40403 Co-Administered With an Opioid Agent for Cancer PainTerminatedNCT00101621Phase 2
- Safety and Efficacy of an Investigational Drug Versus Placebo in the Treatment of Cancer Pain (0663-083)WithdrawnNCT00095017Phase 2
- Marijuana for Cancer PainTerminatedNCT00046709Phase 1/2
- Improving Cancer Pain Management Using AHCPR Cancer Pain GuidelinesCompletedNCT00012896Not applicable